RT Journal Article
SR Electronic
T1 Is it safe to lift COVID-19 travel bans? The Newfoundland story
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.16.20155614
DO 10.1101/2020.07.16.20155614
A1 Linka, Kevin
A1 Rahman, Proton
A1 Goriely, Alain
A1 Kuhl, Ellen
YR 2020
UL http://medrxiv.org/content/early/2020/07/18/2020.07.16.20155614.abstract
AB A key strategy to prevent a local outbreak during the COVID-19 pandemic is to restrict incoming travel. Once a region has successfully contained the disease, it becomes critical to decide when and how to reopen the borders. Here we explore the impact of border reopening for the example of Newfoundland and Labrador, a Canadian province that has enjoyed no new cases since late April, 2020. We combine a network epidemiology model with machine learning to infer parameters and predict the COVID-19 dynamics upon partial and total airport reopening, with perfect and imperfect quarantine conditions. Our study suggests that upon full reopening, every other day, a new COVID-19 case would enter the province. Under the current conditions, banning air travel from outside Canada is more efficient in managing the pandemic than fully reopening and quarantining 95% of the incoming population. Our study provides quantitative insights of the efficacy of travel restrictions and can inform political decision making in the controversy of reopening.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a DAAD Fellowship to Kevin Linka, the Engineering and Physical Sciences Research Council grant EP/R020205/1 to Alain Goriely, and a Stanford Bio-X IIP seed grant and the National Institutes of Health Grant U01 HL119578 to Ellen Kuhl.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data are available on public data bases cited in the text